Kidney international

publication venue for

The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. 2020
A road less traveled. 2014
Medullary amyloidosis associated with apolipoprotein A-IV deposition. 2011
Polycystic liver disease treated with therapeutic excision. 2009
Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. 2003
The Case | A benign reason behind a malignant finding.. 103. 2023
The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease.. 102. 2022
Conditional deletion of myeloid-specific mitofusin 2 but not mitofusin 1 promotes kidney fibrosis.. 101. 2022
COVID-19 infection in kidney transplant recipients at the epicenter of pandemics.. 98. 2020
Consensus definitions for glomerular lesions by light and electron microscopy: recommendations from a working group of the Renal Pathology Society.. 98. 2020
Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease.. 98. 2020
The Case | Knee pain and allograft dysfunction in a kidney transplant recipient.. 97. 2020
Cardiovascular disease care fragmentation in kidney transplantation: a call for action.. 96. 2019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.. 96. 2019
Factors leading to the discard of deceased donor kidneys in the United States.. 94. 2018
Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling.. 93. 2018
Race but not Hepatitis C co-infection affects survival of HIV⁺ individuals on dialysis in contemporary practice.. 93. 2017
The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis.. 92. 2017
A proposal for standardized grading of chronic changes in native kidney biopsy specimens.. 91. 2017
Obesity increases the risk of end-stage renal disease among living kidney donors.. 91. 2016
Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.. 90. 2016
Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury.. 90. 2016
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.. 90. 2016
Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy.. 89. 2016
National outcomes of kidney transplantation from deceased diabetic donors. 2015
Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients.. 88. 2015
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.. 87. 2015
Relation between BK-α/β4-mediated potassium secretion and ENaC-mediated sodium reabsorption.. 86. 2014
Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis.. 86. 2014
Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.. 85. 2014
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.. 85. 2013
The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.. 83. 2013
The mean dietary protein intake at different stages of chronic kidney disease is higher than current guidelines.. 83. 2013
C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.. 82. 2012
Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.. 82. 2012
In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice.. 82. 2012
Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.. 82. 2012
Renal outcomes in hypertensive Black patients at high cardiovascular risk.. 81. 2011
Adenosine A(2A) receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation.. 80. 2011
Targeted inhibition of complement activation prevents features of preeclampsia in mice.. 79. 2010
Serum- and glucocorticoid-regulated kinase 1 is upregulated following unilateral ureteral obstruction causing epithelial-mesenchymal transition.. 78. 2010
The absence of a clathrin adapter confers unique polarity essential to proximal tubule function.. 78. 2010
Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.. 78. 2010
The pelvis-kidney junction contains HCN3, a hyperpolarization-activated cation channel that triggers ureter peristalsis.. 77. 2009
The MILLER banding procedure is an effective method for treating dialysis-associated steal syndrome.. 77. 2009
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.. 77. 2009
Circulating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans.. 76. 2009
Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.. 75. 2009
Ex vivo carbon monoxide prevents cytochrome P450 degradation and ischemia/reperfusion injury of kidney grafts.. 74. 2008
Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure.. 74. 2008
Normal distribution and medullary-to-cortical shift of Nestin-expressing cells in acute renal ischemia.. 71. 2007
Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging.. 68. 2005
Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species.. 68. 2005
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients.. 68. 2005
Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats.. 68. 2005
Liposome-mediated transfer of nitric oxide synthase gene improves renal function in ureteral obstruction in rats.. 66. 2004
Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine.. 65. 2004
Post-transplant nephrotic syndrome: A comprehensive clinicopathologic study.. 65. 2004
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.. 65. 2004
Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.. 65. 2004
Major involvement of CD40 in the regulation of chemokine secretion from human peritoneal mesothelial cells.. 64. 2003
Rapamycin is an effective inhibitor of human renal cancer metastasis.. 63. 2003
Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal failure in the fawn-hooded rat.. 62. 2002
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.. 62. 2002
Renal cell apoptosis in chronic obstructive uropathy: the roles of caspases.. 60. 2001
Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction.. 59. 2001
Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction.. 58. 2000
TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain.. 56. 1999
Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report.. 55. 1999
The Banff 97 working classification of renal allograft pathology.. 55. 1999
Angiotensin II induces superoxide anion production by mesangial cells.. 54. 1998
Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients.. 53. 1998
Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc gamma RIIA alleles.. 52. 1997
Glomerular and vascular tissues do not down-regulate nitric oxide synthesis during protracted endotoxemia.. 52. 1997
Fractional direct dialysis quantification: a new approach for prescription and monitoring hemodialysis therapy.. 50. 1996
Cell apoptosis and proliferation in experimental chronic obstructive uropathy.. 50. 1996
Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy.. 49. 1996
Correlation between Banff classification, acute renal rejection scores and reversal of rejection.. 49. 1996
Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection.. 48. 1995
Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs.. 46. 1994
Cytokine stimulation of prostaglandin production inhibits the proliferation of serum-stimulated mesangial cells.. 45. 1994
Tenascin is an important component of the glomerular extracellular matrix in normal and pathologic conditions.. 45. 1994
Rat mesangial cell hypertrophy in response to transforming growth factor-beta 1.. 44. 1993
Renal receptors and effects of atrial natriuretic factor in compensatory renal hypertrophy.. 42. 1992
Experimental chronic renal ischemia: morphologic and immunologic studies.. 41. 1992
Growth hormone prevents steroid-induced growth depression in health and uremia.. 40. 1991
Chronic tubulo-interstitial nephritis: correlation between structural and functional findings.. 38. 1990
Effects of uninephrectomy and high protein feeding in cyclosporine nephropathy.. 36. 1989
Cyclosporine A induced remission of relapsing nephrotic syndrome in children.. 33. 1988
Effect of immunosuppressants on OKT3 associated T cell activation: clinical implications.. 32. 1987
The existence of a protracted course in crescentic glomerulonephritis.. 31. 1987
Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis.. 30. 1986
Effect of variations in dietary sodium intake on sodium excretion in mature rats.. 27. 1985
Biocompatibility of dialysis membranes: effects of chronic complement activation.. 26. 1984
Kidney transplant nephrotic syndrome: relationship between allograft histopathology and natural course.. 18. 1980
Role of humoral presenitization in human renal transplant rejection.. 17. 1980
Effects of fluorocitrate on renal ammoniagenesis and glutamine metabolism in the intact dog kidney.. 15. 1979
Effect of vasopressin on sodium transport in renal cortical collecting tubules.. 1. 1972
Expanding the use of hepatitis C-viremic kidney donors. 2017
The authors reply. 2021
Role of mast cells in renal fibrosis. 2013
Association of nephrolithiasis prevalence rates with ambient temperature in the United States: a re-analysis. 2009
Ligation of the perforating vein for treatment of steal syndrome in arteriovenous grafts: a hypothesis. 2008
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. 2018
Meeting report on the Bellagio Conference 'prevention of vascular diseases in the emerging world: An approach to global health equity'. 2006
Update on scoring and providing evidence basis for assessing pathology in lupus nephritis.. 103. 2023
Nanomedicines for kidney diseases. 2016
Pros and cons for C4d as a biomarker. 2012
Intracellular cAMP signaling by soluble adenylyl cyclase. 2011
Ambient temperature as a contributor to kidney stone formation: implications of global warming. 2011
Hepatitis B treatment: Lessons for the nephrologist. 2006
The place of sirolimus in kidney transplantation: can we reduce calcineurin inhibitor renal toxicity? 2006
The classification of glomerulonephritis in systemic lupus erythematosus revisited. 2004
The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. 2003
Aldosterone and potassium secretion by the cortical collecting duct. 2000
Effects of gender and genotype on the phenotypic expression of nonmodulating essential hypertension. 2000
Adhesion molecules and rejection of renal allografts. 1997
Acute rejection of renal allografts: mechanistic insights and therapeutic options. 1997
Role of atrial natriuretic factor in volume control. 1996
Sodium-coupled ion cotransport and the volume regulatory increase response. 1989
Renal clearance and isolated kidney perfusion techniques. 1986
Cellular mechanism of hormone action in the kidney: messenger function of calcium and cyclic AMP. 1986
Atrial natriuretic factor: structure and functional properties. 1985
Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. 1979

VIVO Weill Cornell Medical College

Kidney international Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)